Characteristic | Status | Number of patients |
---|---|---|
Stage | I | 8 (16%) |
II | 15 (30%) | |
III | 12 (24%) | |
IV | 9 (18%) | |
Unknown | 6 (12%) | |
Age | < 45 | 20 (40%) |
> 45 | 24 (48%) | |
Unknown | 6 (12%) | |
Lymph node metastasis | Yes | 17 (34%) |
No | 26 (52%) | |
Unknown | 7 (14%) | |
Tumor size (TS) | < 2 cm | 15 (30%) |
5 > TS > 2 | 5 (10%) | |
> 5 cm | 29 (58%) | |
Unknown | 1 (2%) | |
Menopausal status | Yes | 12 (24%) |
No | 15 (30%) | |
Unknown | 23 (46%) | |
ER receptor | Positive | 14 (28%) |
Negative | 13 (26%) | |
Unknown | 23 (46%) | |
PR receptor | Positive | 19 (38%) |
Negative | 21 (42%) | |
Unknown | 10 (20%) | |
HER2/neu receptor | Positive | 12 (24%) |
Negative | 21 (42%) | |
Unknown | 17 (34%) |